Mu‐Chen Zhang

Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial

Mu‐Chen Zhang, Shuang Tian, Di Fu et al. · Cancer Cell · 2023 · 117 citations · Full text

Medicine, Immunology, Oncology +14

Clinical Efficacy and Tumor Microenvironment Influence in a Dose-Escalation Study of Anti-CD19 Chimeric Antigen Receptor T Cells in Refractory B-Cell Non-Hodgkin's Lymphoma

Zi‐Xun Yan, Li Li, Wen Wang et al. · Clinical Cancer Research · 2019 · 113 citations

Life Sciences, Immunology, Oncology +16

Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma

Rong Shen, Di Fu, Lei Dong et al. · Signal Transduction and Targeted Therapy · 2023 · 99 citations · Full text

Medicine, Genetics, Hematology +17

Clinical efficacy and molecular biomarkers in a phase II study of tucidinostat plus R-CHOP in elderly patients with newly diagnosed diffuse large B-cell lymphoma

Mu‐Chen Zhang, Ying Fang, Li Wang et al. · Clinical Epigenetics · 2020 · 51 citations · Full text

Medicine, Oncology, Pharmacology +10

Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkin's lymphoma

Huijuan Zhong, Jia Chen, Shu Cheng et al. · EBioMedicine · 2019 · 42 citations · Full text

Life Sciences, Immunology, Oncology +17